Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Change Your Physical make-up: Compelling Activities for Muscle Building - 2Cocoa Prices Undercut Amid the Prospects of Abundant Supplies
- 3Volcanic eruption led to the Black Death, new research suggests
- 4Illumina unveils dataset to speed up AI-powered drug discovery
- 5Mechanical Sidekick d: A Survey of \Elements and Execution d\ Cell phone
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- The Best Web-based Courses for Ability Advancement
- 'Stranger Things' made him a heartthrob. He left Hollywood anyway.
- Famous Network programs in Europe and America
- The wolf supermoon will kick off 2026 with a celestial bang. Here's when and how to see it.
- Ariana Grande and Jonathan Bailey will reunite for 'Sunday in the Park With George'
- Viable Tips for Seniors to Purchase a Minimal expense Jeep Wrangler
- Go on A Careful spending plan: Modest Objections for Your List of must-dos
